Acknowledgement to Referees Anton van Rensburg Acknowledgement to Referees Open access 29 November 2013 Pages: 241 - 242
The Safety of Besifloxacin Ophthalmic Suspension 0.6 % Used Three Times Daily for 7 Days in the Treatment of Bacterial Conjunctivitis Ranjan MalhotraStacey AckermanCatherine Allaire Original Research Article Open access 19 October 2013 Pages: 243 - 252
Disposition and Metabolism of Setipiprant, a Selective Oral CRTH2 Antagonist, in Humans Matthias HochJanine WankJasper Dingemanse Original Research Article Open access 09 November 2013 Pages: 253 - 269
Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Vanja SikiricaMoshe FridmanM. Haim Erder Original Research Article Open access 23 November 2013 Pages: 271 - 280
An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report David HobbsJamie KaragianisJoel Raskin Short Communication Open access 30 October 2013 Pages: 281 - 288
Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer José Rodrigues PereiraRebecca ChengHelen Barraclough Short Communication Open access 26 November 2013 Pages: 289 - 296